A topical microemulsion for the prevention of allergic rhinitis symptoms: Results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)

Allergy, Asthma and Clinical Immunology

Volumn 9, Issue 1, 2013, Pages

  Ojeda, Pedro ^a   Piqué, Núria ^b   Alonso, Alicia ^c   Delgado, Julio ^d   Feo, Francisco ^e   Igea, Juan M ^f   Navarro, Ana ^g   Olaguibel, José M ^h   Subiza, Javier ⁱ   Nieto, Carles ^j   Andersson, Morgan ^k  

^a Clínica de Asma y Alergia Dres ^*  (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Unidad de Neurologia   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e General University Hospital of Ciudad Real   (Spain)

^f Clinica Alergoasma   (Spain)

^g Pulmonology Section   (Spain)

^h Instituto de Investigación Sanitaria de Navarra   (Spain)

ⁱ Clínica Subiza de Asma y Alergia   (Spain)

^j R+D Division Biotechnology Development   (Spain)

^k LUND UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Allergen avoidance; Allergic rhinitis; Barrier measures; Corticosteroids use; Efficacy; Nasal symptoms; Natural pollen exposure; Quality of life; Rhinoconjunctivitis; Safety

Indexed keywords

PLACEBO;

ADULT; ARTICLE; BIRCH; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEASIBILITY STUDY; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; MULTICENTER STUDY; NOSE OBSTRUCTION; OLIVE TREE; PARALLEL DESIGN; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SENSITIZATION; SPAIN; STATISTICAL SIGNIFICANCE; SWEDEN;

EID: 84883517901     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-9-32     Document Type: Article

References (13)

1. Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. Int Immunopharmacol 2011, 11:1646-1662. 10.1016/j.intimp.2011.07.005, 21784174.
2. Willsie SK. Improved strategies and new treatment options for allergic rhinitis. J Am Osteopath Assoc 2002, 102:S7-S14.
3. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ. Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010, 126:466-476. 10.1016/j.jaci.2010.06.047, 20816182.
4. Åberg N, Dahl T, Benson M. A nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load. Paediatric Allergy Immunol 2011, 22:594-599.
5. Andersson M, Greiff L, Wollmer P. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis. Acta Otolaryngol 2008, 128:666-669. 10.1080/00016480701642197, 18568502.
6. Andersson M, Greiff L, Wollmer P. Effects of a topical microemulsion in house dust mite allergic rhinitis. Basic Clin Pharmacol Toxicol 2011, 108:146-148. 10.1111/j.1742-7843.2010.00640.x, 21231989.
7. Valero A, Alonso J, Antépara I, Baró E, Colás C, del Cuvillo A, Ferrer M, Herdman M, Marti-Guadaño E, Monclús L, Navarro-Pulido AM, Sastre J, Izquierdo I, Mullol J. Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires. Allergy 2007, 62:1372-1378. 10.1111/j.1398-9995.2007.01552.x, 17983372.
8. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000, 30:132-140. 10.1046/j.1365-2222.2000.00668.x, 10606940.
9. Garavello W, Romagnoli M, Gaini RM. Hypertonic or isotonic saline for allergic rhinitis in children. Pediatr Allergy Immunol 2005, 16:91-92. 10.1111/j.1399-3038.2005.00215.x, 15693919.
10. Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery systems. I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate. Eur J Pharm Sci 1998, 6:231-239. 10.1016/S0928-0987(97)10004-5, 9795071.
11. Josling P, Steadman S. Use of cellulose powder for the treatment of seasonal allergic rhinitis. Adv Ther 2003, 20:213-219. 10.1007/BF02850092, 14669817.
12. Emberlin JC, Lewis RA. A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin 2006, 22:275-285. 10.1185/030079906X80440, 16466599.
13. Emberlin JC, Lewis RA. A double blind, placebo-controlled crossover trial cellulose powder by nasal provocation with Der p1 and Der f1. Curr Med Res Opin 2007, 23:2423-31. 10.1185/030079907X231144, 17767803.